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Abstract
Background: Retaining patients with HIV infection in care is still a major challenge
in sub- Saharan Africa, particularly in the Democratic Republic of Congo (DRC)
where the antiretroviral treatment (ART) coverage is low. Monitoring retention is an
important tool for evaluating the quality of care.
Methods and Findings: A review of medical records of HIV -infected children was
performed in three health facilities in the DRC: the Amo-Congo Health center, the
Monkole Clinic in Kinshasa, and the HEAL Africa Clinic in Goma. Medical records of
720 children were included. Kaplan Meier curves were constructed with the
probability of retention at 6 months, 1 year, 2 years and 3 years. Retention rates
were: 88.2% (95% CI: 85.1%–90.8%) at 6 months; 85% (95% CI: 81.5%–87.6%) at
one year; 79.4% (95%CI: 75.5%–82.8%) at two years and 74.7% (95% CI: 70.5%–
78.5%) at 3 years. The retention varied across study sites: 88.2%, 66.6% and
92.5% at 6 months; 84%, 59% and 90% at 12 months and 75.7%, 56.3% and
85.8% at 24 months respectively for Amo-Congo/Kasavubu, Monkole facility and
HEAL Africa. After multivariable Cox regression four variables remained
independently associated with attrition: study site, CD4 cell count ,350 cells/mL,
children younger than 2 years and children whose caregivers were member of an
independent church.
Conclusions: Attrition remains a challenge for pediatric HIV positive patients in
ART programs in DRC. In addition, the low coverage of pediatric treatment
exacerbates the situation of pediatric HIV/AIDS.
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Introduction
According to the UNAIDS 2013 report, worldwide 3.3 million children under 15
years were living with HIV in 2012. Over 90% of these infected children live in
sub-Saharan Africa [1]. It was estimated that during the same year 260,000 new
HIV infections occurred among children, most of them as a result of mother-to-
child transmission of HIV (MTCT) [1]. Mother-to-child transmission rates
declined overall from an estimated 26% in 2009 to 17% in 2012, and coverage of
prevention of mother -to-child transmission (PMTCT) services increased to 65%.
The number of children younger than 15 years receiving ART increased to 34%
[1]. However, these summary estimates comprise enormous disparities between
the different countries [1]. In 2012, the coverage of PMTCT services in the
Democratic Republic of Congo (DRC) was estimated to be only 13%, and only
9% of children younger than 15 years in need of ART (according to the WHO
2010 guidelines) were receiving ART [2, 3].
Evidence shows that early administration of ART in HIV-infected infants
reduces mortality and HIV progression by 75% [4]. However, achieving this
depends on several factors, including the early diagnosis of HIV infection,
adequate quality of antiretroviral (ARV) drug prescription, good support for
children on ART and maintaining/retaining these HIV-infected children in care
and ART programs [4, 5].
Patients’ retention in care programs remains a major challenge in sub- Saharan
Africa [6–10]. It is also one of the key indicators to assess the success of ART
programs [6].
Retention rates among children vary from 71 to 95% at one year, and between
62 and 93% at 2 years in sub-Saharan Africa [5].
To maximize retention in ART programs, a number of factors need to be
considered: structural factors such as transportation, availability and accessibility
of services, service providers’ attitude, caregiver’s HIV status and religious and
other beliefs (traditional healers), and patient-related factors [11, 12].
The objective of this study was to determine retention rates of HIV-infected
children on ART in three different programs and sites in the DRC, and to assess
risk factors for attrition. Based on the study findings, we propose recommenda-
tions to improve retention in pediatric HIV care and treatment programs.
Methods
Study Sites
Three facilities, known to offer care for HIV infected children and with a sufficient
number of patients were asked and agreed to participate in the study. Two of these
facilities are located in Kinshasa, the capital of the DRC (an Amo-Congo health
facility and the Centre Hospitalier Monkole). The third facility (HEAL Africa) is
located in Goma, the capital city in the North Kivu province (Fig. 1). Amo-Congo
is a Congolese non-governmental organization (NGO) that began in 1993 with
providing support for orphans and vulnerable children in Kinshasa. Over the
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years this NGO expanded its activities to several provinces and included voluntary
counseling and testing, and provision of HIV care to adults and children. In 2005
Amo-Congo started, with financial support from Global Fund for AIDS
Tuberculosis and Malaria (GFATM) with the provision of ART in their
Ambulatory Treatment Centers (ATCs), which are standalone clinics that offer
counseling and testing, and HIV care. This study was conducted at the ATC in
Kasa-vubu in Kinshasa.
The ‘‘Centre Hospitalier Monkole’’, the Monkole Hospital, is a private health
hospital (55 beds), in the Mount Ngafula I health zone in Kinshasa which started
its activities in 1991. Their HIV unit started activities in 2005 with financial
support from GFATM through the United Nations Development Programme
(UNDP), and organizes HIV activities such as HIV prevention activities, ART and
management of opportunistic infections. Both the Amo-Congo and Monkole
health facility serve an urban population.
HEAL Africa Hospital was started in 1998 and is located in Goma/North- Kivu,
and serves as a center of excellence for the province. It has 155 beds and works
with 4 services/departments including surgery, internal medicine, pediatrics and
Fig. 1. Map of the Democratic Republic of Congo with provincial HIV prevalence.
doi:10.1371/journal.pone.0113877.g001
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obstetrics and gynecology. The HIV/AIDS pediatric care service of this facility is
called AIDS Children Program (CAP), and was integrated into HEAL Africa
hospital in 2005 (with financial support from UNICEF, Global Strategies and the
Clinton Foundation). This facility serves populations from peri-rural and rural
areas, and supports community organization in the rural area.
Study type and inclusion criteria
From October 2012 to August 2013, we conducted a retrospective cohort study of
HIV-infected children on ART at these three health facilities in the DRC.
Children older than 6 months and younger than 15 years at the moment of data
collection who had initiated ART at least three months prior to data collection
were included in the study.
Data collection
We conducted a retrospective chart review of 720 medical charts. In each of the
three research sites a random sample of medical charts was selected from a
sampling frame that consisted of all children ever started on ART at that site
between September 2007 and May 2012. The sampling frame was prepared by the
site supervisor; the list of the medical files to be selected was generated by the data
analyst using a computerized random number generator (‘sample’ function in
Stata). Randomly selected children that were not eligible for the study were
replaced by the next child in the sampling frame. Only one child per family was
included in the study (the first child from the family on the list).
A specifically designed study form was used for data abstraction, which was
carried out by a team of two nurses. All the members of the study team were
trained in ethics (for confidentiality issues) and data abstraction.
Data analysis and sample size
A random sample of 250 ART-treated children in each site was needed to allow
the estimation of the retention rate to be measured with a precision of 5%,
assuming the retention rate was at least 80%. In all three study sites, patients
received ARV medication according to the WHO 2010 guidelines [3]. Once on
ART, HIV-positive children were required to come to the clinic every three
months. The child or the caregiver/guardian had to go to the pharmacy every
month to collect the ARV drugs. A child or caregiver visiting the clinic within the
three months preceding the data collection was considered to be retained in the
program.
Attrition was defined as death or loss to follow-up. Lost to follow up stands for
a person under treatment and missing the scheduled visits beyond 90 days [13].
Multivariable Cox regression was used to assess the association between
retention and other variables in the models. The following baseline variables were
assessed as potential risk factors for attrition: age, gender, clinical stage, CD4
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count at ART start, presence of opportunistic infection, hemoglobin, weight (z-
score weight-for-age), height (z-score height-for-age) and education level as
children’s characteristics; age, education level, gender, religion, profession, civil
status and relation with the child as caregivers’ characteristics. Variables with p-
value #0.10 during univariable analysis were considered for inclusion in the
multivariable model. Z-scores for weight-for-age and height-for-age were
generated using the 2006 WHO growth standards and the zscore06 module in
Stata (http://www.ifpri.org/staffprofile/jefleroy).
The complex model was reduced by stepwise backwards elimination approach.
Study site was included in the model as a fixed effect. All associations were tested
using likelihood-ratio tests.
For variables with less than 10% missing values conditional imputation was
used and for variables with at least 10% missing data the missing indicator
method (in which a separate category is generated for patients with data missing
for a certain predictor). As HEAL Africa Hospital had the highest number of
children in care, this site was considered as the reference site. Epi infoTM 7.0.9.34
was used to enter data from all the sites by a trained data manager in Kinshasa.
The data analysis was conducted using Epi info and Stata 11.
Ethics statement
The study protocol was approved by the Institutional Review Board (IRB) of the
Kinshasa School of Public Health at the University of Kinshasa. All study
members were trained in human subject research and good clinical practices.
Due to the nature of the study it was not possible and feasible to obtain
informed consent from the patients whose medical charts were abstracted for the
study. Data were extracted from routine records, and were analyzed anonymously.
Results
The number of HIV infected children under ART did not reach 250 as was
reported by the Amo-Congo and Monkole facilities. Therefore in total only 720
medical files of children on ART were available at the three study sites. Applying
the inclusion criteria, 198 patient files were excluded: 77 patients were above 15
years at the moment of data collection, in 58 files the date of ART initiation was
missing and 63 patients started ART within 3 months prior to data collection.
After this process, 522 patient files were selected and included for the analysis. The
details regarding patient flow are presented in Fig. 2.
Children’s characteristics (Table 1)
From 2007 to 20012, 522 HIV positive children were included in the analysis. The
mean age of the children was 4.7 years (standard deviation [SD]: 3.3); 80% were
in WHO clinical stage 3 or 4 at the start of ART. The first line ART regimen
provided to 65% of the children was Zidovudine + Lamivudine + Nevirapine
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(AZT/3TC/NVP). The proportion of children who did not yet attend school was
43%; 27% attended primary school.
Care givers’ characteristics (Table 2)
In 51%, the children’s caregivers were direct parents (either mother of father).
Among the caregivers, 51% were male and the mean age of the caregivers was 42
years (SD: 13). Those who had a formal job represented 53% of the caregivers,
66% had at least the secondary school education. 42% of the caregivers were
married, 62% belonged either to the catholic or protestant church, and 37% to the
independent church.
Retention
The overall retention probabilities are presented in Fig. 3. Overall retention rates
were 88% (95% CI [95% confidence interval]: 85%–91%) at 6 months, 85% (95%
CI: 81%–87%) at one year, 79% (95%CI: 75%–83%) at two years and 74% (95%
CI: 70%–78%) at 3 years. The overall median time in the ART program was 3
years (IQR [inter quartile range]: 1.3–5.0), with site-specific median times of 2.5
years (IQR: 1.3–4.6) at AMO-Congo Kasavubu, 1.5 years (IQR: 1.2–3.5) at the
Monkole facility and 3.5 (IQR: 1.5–5.0) years at the HEAL Africa facility in Goma.
Fig. 2. Study flow of participants in three different HIV treatment centers in the Democratic Republic of
Congo.
doi:10.1371/journal.pone.0113877.g002
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Table 1. Children’s characteristics in three different programs and sites in the Democratic Republic of Congo.
Children’s characteristics Amo-Congo Kinshasa Monkole Kinshasa HEAL Africa Goma Total
Total, n (%) 147 (28.16) 61(11.69) 314(60.15) 522(100.0)
Age (years), n (%)
#2 47 (31.9) 34 (55.7) 106 (33.8) 187 (35.8)
.2- more 100 (68.1) 27 (44.3) 208 (66.2) 335 (64.2)
Sex, n (%)
Male 76 (51.8) 30 (49.2) 160 (51.0) 266 (51.0)
Female 71 (48.2) 31 (50. 8) 154 (49.0) 256 (49.0)
Education, n (%)
Not yet eligible 47 (31.9) 34 (55.8) 252 (80.2) 333 (63.8)
Kindergarden 14 (9.5) 3 (4.9) 4 (1.3) 21 (4.0)
Primary 72 (48.9) 18 (29.5) 56 (17.8) 146 (27.9)
Secondary 2 (1.4) 0 (0.0) 2 (0.7) 4(0.7)
Missing 12(8.3) 6(9.8) 0(0.0) 18(3.5)
Weight-for-age z-score, n (%)
,22 SD 19(12.9) 25(41.0) 83(26.4) 127(24.3)
$22 SD 85(57.8) 18(29.5) 122(38.9) 225(43.1)
Missing 43(29.3) 18(29.5) 109(34.7) 170(32.6)
Height-for-age z-score, n (%)
,22 SD 10(6.8) 5(8.2) 76(24.2) 91(17.4)
$22 SD 38(25.9) 5(8.2) 109(34.7) 152(29.1)
Missing 99(67.3) 51(83.6) 129(41.1) 279(53.5)
Clinical stage, n (%)*
WHO I 21 (14.3) 5 (8.2) 1 (0.3) 27 (5.2)
WHOII 55 (37.4) 17 (27.9) 4 (1.3) 76 (14.5)
WHO III 64 (43.5) 36 (59.0) 306 (97.5) 406 (77.8)
WHO IV 7 (4.8) 3 (4.9) 3 (0.9) 13 (2.5)
Drug regimen, n (%)
AZT/3TC/NVP 84 (57.1) 49 (80.3) 207 (65.9) 340 (65.1)
3TC/D4T/NVP 36 (24.5) 9 (14.7) 92 (29.3) 137 (26.2)
Other 27 (18.3) 3 (4.9) 15 (4.8) 45 (8.7)
CD4 cell count* (cells/mL), n (%)
0–200 49 (33.3) 25 (40.9) 120 (38.3) 194 (37.1)
.200–350 24 (16.3) 7 (11.5) 52 (16.5) 83 (15.9)
.350-more 27 (18.5) 7 (11.5) 89 (28.4) 123 (23.6)
Missing 47(31.9) 22(36.1) 53(16.8) 122(23.4)
Cotrimoxazole, n (%)
No 2 (1.4) 33 (54.1) 12 (3.8) 47 (9.0)
Yes 145 (98.6) 28 (45.9) 302 (96.2) 475 (91.0)
*At the start of antiretroviral treatment.
doi:10.1371/journal.pone.0113877.t001
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Site-specific retention rates were 88%, 67% and 92% at 6 months; 84%, 59% and
90% at 12 months and 76%, 56% and 86% at 24 months, respectively for Amo-
Congo/Kasa-vubu, Monkole facility and HEAL Africa (Fig. 4).
Table 2. Characteristics of the child’s caregiver in three different programs and sites in the Democratic Republic of Congo.
Caregivers’ characteristics Amo-Congo Kinshasa Monkole Kinshasa HEAL Africa Goma Total
Total, n (%) 147 (28.16) 61(11.69) 314(60.15) 522 (100.0)
Type of Caregiver, n (%)
Mother 43 (29.3) 20 (32.8) 152 (48.4) 215 (41.2)
Father 31 (21.1) 11 (18.0) 50 (15.9) 92 (17.6)
Grandparent 9 (6.1) 3 (4.9) 22 (7.1) 34 (6.5)
Brother/sister 29 (19.7) 15 (24.6) 47 (14.1) 91 (17.5)
Other 35 (23.8) 12 (19.7) 43 (13.7) 90 (17.2)
Age (years), n (%)
.15–35 32 (21.8) 11 (18.6) 115 (36.6) 158 (30.4)
.35–45 46 (31.3) 21 (35.6) 92 (29.3) 159 (30.6)
.45 63 (42.8) 20 (33.9) 86 (27.4) 169 (32.5)
Missing 6(4.1) 7(11.9) 21(6.7) 34(6.5)
Sex, n (%)
Female 91 (61.9) 33 (54.1) 230 (73.3) 354 (67.8)
Male 56 (38.1) 28 (45.9) 84 (26.7) 168 (32.2)
Profession, n (%)
Housewife 48 (32.7) 15 (28.8) 123 (39.2) 186 (35.6)
Student 10 (6.8) 4 (7.6) 27 (8.6) 41 (7.9)
Employee 35 (23.8) 16 (26.2 60 (19.1) 111 (21.3)
Trader 46 (31.3) 17 (27.8) 88 (28.1) 151 (28.9)
Missing 8(5.4) 9(14.8) 16(5.1) 33(6.3)
Religion, n (%)
Catholic 44 (29.9) 14 (22.9) 109 (34.7) 167 (32.0)
Protestant 11 (7.5) 14 (22.9) 102 (32.5) 127 (24.3)
Independent 65 (44.2) 20 (32.9) 55 (17.5) 140 (26.8)
Other 22 (15.0) 8 (13.1) 36 (11.5) 66 (12.6)
Missing 5(3.4) 5(8.2) 12(3.8) 22(4.2)
Education, n (%)
Primary and less 26 (17.7) 12 (19.7) 128 (40.8) 166 (31.8)
Secondary 83 (56.5) 27 (44.2) 132 (42.1) 242 (46.4)
Higher education 35 (23.8) 10 (16.4) 39 (12.3) 84 (16.1)
Missing 3(2.0) 12(19.7) 15(4.8) 30(5.7)
Marital status, n (%)
Not maried 25 (17.0) 8 (13.1) 32 (10.1) 65 (12.5)
Married (Poly and monogamous) 53 (36.1) 15 (24.5) 150 (47.8) 218 (41.8)
Widowed 37 (25.2) 11 (18.0) 80 (25.5) 128 (24.5)
Missing 32(21.7) 27(44.3) 52(16.6) 111(21.3)
doi:10.1371/journal.pone.0113877.t002
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Out of the 522 HIV infected children, 109 (20.8%) were lost from the ART
program: 22 (20%) had died, 87 (80%) were lost to follow-up and, 4 (4%) were
transferred to other ART programs.
Fig. 3. Overall retention rates for children on ART in three different HIV treatment centers in the
Democratic Republic of Congo.
doi:10.1371/journal.pone.0113877.g003
Fig. 4. Retention rates for children on ART by facility in three different programs and sites in the
Democratic Republic of Congo.
doi:10.1371/journal.pone.0113877.g004
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Risk factors for attrition (Table 3)
The following variables were considered in the multivariable model: study site, the
child’s age, CD4 count, education level and uptake of Cotrimoxazole; type, gender
and religion of caregiver. In the final model four variables remained associated
with children’s attrition from ART programs: study site, the child’s age and CD4
count at ART start and religion of the caregiver. Patients enrolled in the Monkole
facility (aHR: 4.77, 95% CI: 2.90–7.85) were likely to experience higher risk of
attrition compared to the patients enrolled in care at the HEAL Africa hospital.
Children #2 years age (aHR: 2.16, 95% CI: 1.48–3.16) experienced higher
attrition compared to older children (Fig. 5). Children with a CD4 cell count
#200/mL (aHR: 2.70, 95% CI: 1.40–5.21) and those with a CD4 cell count
between .200–,350/mL (aHR: 2.87, 95% CI: 1.36–6.07) were likely to experience
higher risk of attrition compared to children with CD4 count $350/mL.
Children whose caregivers were affiliated to the independent church (aHR:
1.86; 95% CI: 1.19–2.90) were more likely to experience attrition compared to
those whose caregivers were affiliated to the catholic and protestant church.
Risk factors for loss to follow up and death (Table 4)
In multivariate analysis, four variables remained associated with loss to follow up:
study site, the child’s age and CD4 count at ART start and religion of the
caregiver. Children enrolled in the Monkole facility (aHR: 3.41, 95% CI: 1.98–
Table 3. Risk factors for attrition in three different programs and sites in the Democratic Republic of Congo.
Riskfactor Participants N(%)
Unadjusted HR
(95% CI) Adjusted HR (95% CI) P-value
Study site, n (%) HEAL Africa 314 (60.5) 1 1 ,0.001
Amo-Congo 147 (27.9) 2.29 (1.54–3.42) 2.15 (1.35–3.40)
Monkole 61 (11.6) 5.14 (3.32–7.94) 4.77 (2.90–7.85)
Initial age of Child (years), n (%) .2 years 334(66.2) 1 1 ,0.001
#2 years 170(33.8) 2.41(1.71–3.40) 2.16 (1.48–3.16)
Initial CD4 cell count of child
(cells/mL), n (%)
$350-more 121 (23.4) 1 1 0.039
.200–,350 83 (15.9) 3.12 (1.55–6.27) 2.87 (1.36–6.07)
.0–200 193 (37.2) 3.29 (1.77–6.11) 2.70 (1.40–5.21)
Missing 122 (23.5) 3.80 (1.98–7.29) 2.24 (1.11–4.51)
Education of child, n (%) Primary or less 138 (27.6) 1 / /
Secondary school 149 (29.7) 2.74 (1.56–4.82)
Not yet eligible 214 (42.7) 2.90 (1.70–4.95)
Religion of caregiver, n (%) Catholic 166 (33.4) 1 1 0.003
Protestant 144 (29.0) 0.78 (0.44–1.36) 1.90 (0.51–1.59)
Independant/other 187 (37.6) 2.07 (1.34–3.21) 1.86 (1.19–2.90)
HR: Hazard Ratio; CI: Confidence Interval;
P-value from Cox-regression model adjusted for all factors in final model, including site as a fixed effect.
doi:10.1371/journal.pone.0113877.t003
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Fig. 5. Retention rates for children on ART by age categories in three different programs and sites in
the Democratic Republic of Congo.
doi:10.1371/journal.pone.0113877.g005
Table 4. Risk factors associated with LTFU and death among children in three study sites.
Loss to follow up Reported deaths
Riskfactor
Unadjusted HR
(95% CI)
Adjusted HR
(95% CI)
Unadjusted HR
(95% CI)
Adjusted HR
(95% CI)
Study site HEAL Africa 1 1 1 1
Amo-Congo 2.28 (1.49–3.50) 2.06(1.27–3.36) 9.52(4.15–21.83) 7.22(2.92–17.84)
Monkole 4.31 (2.69–6.92) 3.41(1.98–5.86) 12.63(5.14–30.99) 7.49(2.84–19.77)
Initial age of Child (years) .2 years 1 1 1 1
#2 years 2.20(1.52–3.18) 1.89(1.25–2.85) 1.80(1.03–3.14) 2.78(1.19–6.51)
Initial CD4 cell count of child (cells/mL) $350-more 1 1 1 /
.200–,350 3.81 (1.74–8.33) 3.80 (1.64–8.77) 1.47 (0.55–3.92)
.0–200 3.70 (1.82–7.51) 3.13 (1.46–6.68) 1.14 (0.48–2.69)
Missing 4.29 (2.04–9.00) 2.83 (1.27–6.29) 2.64 (1.15–6.04)
Education of child Primary or less 1 / 1 /
Secondary school 2.47 (1.39–4.38) 4.37 (1.64–11.61)
Not yet eligible 2.31 (1.34–3.97) 2.48 (0.92–6.66)
Religion of caregiver Catholic 1 1 1 /
Protestant 0.85 (0.46–1.54) 1.02 (0.55–1.88) 0.33 (0.10–1.01)
Independant/other 2.10 (1.31–3.37) 1.79 (1.10–2.90) 2.02 (1.04–3.90)
HR: Hazard Ratio; CI: Confidence Interval.
doi:10.1371/journal.pone.0113877.t004
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5.86) were likely to experience higher risk of loss to follow up compared to the
patients enrolled in care at the HEAL Africa hospital. Children#2 years age (aHR:
1.89, 95% CI: 1.25–2.85.) experienced higher risk of loss to follow up compared to
older children. Children with a CD4 cell count #200/mL (aHR: 3.13, 95% CI:
1.46–6.68) and those with a CD4 cell count between .200–,350/mL (aHR: 3.80,
95% CI: 1.64–8.77) were likely to experience higher risk of loss to follow up
compared to children with CD4 count $350/mL. Children whose caregivers were
affiliated to the independent church (aHR: 1.79; 95% CI: 1.10–2.90) were more
likely to experience attrition compared to those whose caregivers were affiliated to
the catholic and protestant church.
Two variables remained associated with death: study site and the child’s age.
Patients enrolled in the Monkole facility (aHR: 7.49, 95% CI: 2.84–19.77) were
likely to experience higher risk of death compared to the patients enrolled in care
at the HEAL Africa hospital. Children#2 years age (aHR: 2.78 95% CI: 1.19–6.51)
experienced higher risk of death compared to older children.
Discussion
Retention rates varied widely across the study facilities: between 93% and 67% at 6
months; 90% and 59% at 12 months and 86% to 56% at 24 months. The highest
retention rate was found in Goma, which can be described as a mixture of a peri-
rural and rural setting. The community support organization active in this rural
area may have played a role in retaining ART patients as was also observed in
other settings [14]. Our findings corroborate also with other studies that report
higher retention rates in rural areas compared to urban areas [4, 15–20].Retention
rates among children on ART in our study were high compared to another study
conducted among adults in the DRC, where retention rates of 81%, 75%, 65% and
57%, respectively at 6 months, one year, two years and three years were found
[21]. Somehow these better results among children highlight the low quality of
care level for patients with HIV infection in the DRC in general.
In the DRC the coverage in HIV care services is amongst the lowest in the
world. PMTCT interventions remain the entry point for pediatric care treatment
in DRC, but PMTCT coverage is very low (13%) [2]. Also coverage of family
planning in DRC is very low, only 6% of women of childbearing age have access to
family planning [22]. The ART coverage in adults is less than 20%, with huge
disparities across the country and alarming figures in the rural areas. ART
coverage is even more dramatic in children: 9% in 2012 [2]. As a consequence of
this low coverage of family planning, PMTCT and ART the number of HIV
infected children is increasing. Advocacy and increased commitment from
government and international organizations is needed to increase services for
family planning, PMTCT and ART coverage [2]. HIV services should be
implemented in all health facilities allowing nurses to provide the ARV.
Retention rates were significantly higher in HIV specialized facilities like HEAL
Africa and Amo-Congo/Kasa-vubu compared to Monkole which is a general
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hospital and which offers a packet of integrated health services. In the DRC, most
of public facilities are general health facilities that do not pay special attention to a
complex health issue such as HIV. Poor quality of health services is associated
with high attrition rates [23].
Patients with a CD4 cell count,350/mL were more likely to experience attrition
compared to those with higher CD4 counts. We should be cautious about the
interpretation of these findings. More than 10% of data on CD4 cell count was
missing and the CD4 cell count percentage (to determine the eligibility for ART in
children) was not available for most of the children. We speculate that children
with a CD4 cell count ,350/mL were at higher risk of mortality and lost to follow
up as reported in other studies where attrition was associated with advanced
disease stage [4–6].
Younger children (#2 years) were also more likely to experience attrition.
These findings corroborate with others studies conducted in developing countries
[5–6, 24]. The children whose caregivers were affiliated to the independent
churches were more likely to experience attrition compared to those whose
caregivers were affiliated to the catholic church or protestant church. These
independent churches often promise miracle healing. Therefore patients affiliated
to these churches are more at risk for attrition. These findings corroborate with
others studies where independent church members appear to have lower uptake of
health services [25, 26]. Given the impact of religion on people in the DRC,
collaboration with religious leaders could help to convince caregivers about the
importance not to stop the ART. Specific training sessions for religious leaders
about this topic should be considered.
Reinforcement of community interventions such as the ‘‘Mentor Mothers
(MM)’’ and ‘‘Community ART groups (CAG)’’ is critical [27, 28]. MM approach
consists of using HIV positive peer mothers to support, educate, and empower
other pregnant women, new mothers and their partners [27]. CAG are peer
support groups that provide psychosocial support to HIV-positive women, men,
and children in their own community [28]. Each CAG comprises between 6 to 12
members and keeps linkage with the health facility in order to receive ARVs and
clinical support as needed. CAG members organize themselves to meet and
provide peer support without involvement of the health providers. These support
groups also play a key role in defaulter tracing and encouraging attendance at
health facility appointments. The CAG approach helps to reduce the frequency of
drugs’ collection from the pharmacy and therefore the cost for traveling to the
clinic. One patient (volunteer) travels to the clinic to collect ARVs for other
members of the CAG. The CAG strategy was shown to improve significantly
patients’ retention and adherence [14, 28].
Our study has several limitations. As in most retrospective studies, some
important information was not available in the medical charts e.g. weight, height
and CD4%. Moreover, we were unable to assess the influence of the caregivers
HIV status because this information was only available in a few of them. Other
studies have shown that an HIV positive status of the caregiver may have a
negative impact on the children’s retention [28].
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Our study was performed in three non-public facilities. We speculate that the
support provided to these facilities had a positive impact on the quality of data
and services. Results may be worse in public facilities in the DRC where the
support is scarce.
In conclusion, attrition remains a challenge for pediatric HIV positive patients
in ART programs in the DRC. In addition, the low coverage of pediatric treatment
and the delayed start of ART exacerbate the situation of pediatric HIV/AIDS.
Whilst moving towards the new 2013 WHO guidelines [29], serious commitment,
in terms of government’s political will and more support from the international
donors, is needed to increase access to ART and retention in ART programs.
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